News
Laurent Pharmaceuticals featured in BioCentury Magazine
15 September 2015
Laurent Pharmaceuticals Inc. announced today that the LAU-7b program addressing aberrant inflammation is featured in the September 14th issue of BioCentury, one of...
Read MoreLaurent Pharmaceuticals announces positive Phase 1b topline results for LAU-7b in Cystic Fibrosis
15 June 2015
LAU-7b is safe and well tolerated by adult Cystic Fibrosis (CF) patientsThe pharmacokinetic profile fully achieved the protocol dose selection rationaleStudy...
Read MoreEVENTS
Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA
Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022
Laurent Pharma to participate to BiotechGate, February 7-9, 2022
Laurent Pharma to participate to Biotech Showcase, January 9-11 and 17-19, 2022
Laurent Pharma to participate to H.C. Wainwright 23rd Annual Global Investment Conference,
September 13-15, 2021
September 13-15, 2021